Kyle Rasbach

Insider Reports History

Location
New York, NY
Signature
/s/ Youjin Choi, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kyle Rasbach:

Company Role Class Num Shares Value Price $ Report Date Ownership
Lexeo Therapeutics, Inc. Chief Financial Officer Common Stock 40,875 $335,032 $8.20 17 Jan 2025 Direct
Lexeo Therapeutics, Inc. Chief Financial Officer Stock Option (right to buy) 245,250 17 Jan 2025 Direct

Insider Reports Filed by Kyle Rasbach

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LXEO Lexeo Therapeutics, Inc. 17 Jan 2025 2 $0 4 Chief Financial Officer 22 Jan 2025, 16:55
LXEO Lexeo Therapeutics, Inc. 18 Dec 2024 0 $0 3 Chief Financial Officer 27 Dec 2024, 14:59